Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Tesamorelin vs. Other GHRH Analogues: A Legal and Functional Comparison

Tesamorelin doesn't exist in a vacuum. It's part of a class of peptides known as GHRH analogues, each with its own unique structure and research profile. Understanding the differences is key for any researcher planning a study in this area. Our experience show

This comparison does not assign a generated winner or score.

  • Tesamorelin doesn't exist in a vacuum. It's part of a class of peptides known as GHRH analogues, each with its own unique structure and research profile. Understanding the differences is key for any researcher planning a study in this area. Our experience shows that comparing them side-by-side often clarifies which compound is the right tool for the job.
  • Here’s a quick breakdown of some of the most common GHRH analogues:
  • Structure
  • Full 44 amino acid chain of GHRH with a trans-hexenoyl group modification.
  • The first 29 amino acids of the GHRH chain.
  • A 29 amino acid peptide with modifications for stability and a Drug Affinity Complex (DAC).
  • Half-Life
  • Relatively short (around 30-40 minutes).
  • Very short (around 10-12 minutes).
  • Very long (up to 8 days) due to the DAC binding to albumin.
  • Primary Use
  • FDA-approved for HIV-associated lipodystrophy.
  • Previously used off-label for anti-aging; now mostly a research compound.
  • Strictly a research compound; never approved for human use.
  • Legal Status
  • Prescription drug; available as a research compound.
  • Available as a research compound; some compounding pharmacies may still make it.
  • Available exclusively as a research compound.
  • Research Focus
  • Visceral fat reduction, cognitive enhancement, nerve regeneration.
  • General GH release, cellular repair, sleep quality.
  • Sustained GH release, long-term metabolic effects.
  • As you can see, while they all stimulate the pituitary, their structure, half-life, and legal standing create very different profiles. A researcher studying pulsatile GH release might find Sermorelin more appropriate, while someone investigating long-term metabolic shifts might lean toward a compound like CJC-1295 Ipamorelin. The choice is driven by the scientific question you're asking.
More references

Related material